Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Intern Med ; 63(3): 425-431, 2024 Feb 01.
Article in English | MEDLINE | ID: mdl-37344441

ABSTRACT

A 52-year-old Japanese woman developed type 1 diabetes mellitus (type 1 DM) at 41 years old. She became complicated with Hashimoto's disease and showed swelling of both submandibular glands, which was diagnosed as IgG4-related disease (IgG4-RD). This is a rare case of a Japanese patient with autoimmune polyglandular syndrome type 3A (APS-3A) coexisting with autoimmune thyroid disease (AITD) and type 1 DM complicated by IgG4-RD. Bilateral submandibular gland resection was successfully performed without steroid therapy. We discuss the possibility that the immunological pathogenic mechanisms of APS-3A and IgG4-RD are related.


Subject(s)
Autoimmune Diseases , Diabetes Mellitus, Type 1 , Hashimoto Disease , Immunoglobulin G4-Related Disease , Polyendocrinopathies, Autoimmune , Female , Humans , Adult , Middle Aged , Immunoglobulin G4-Related Disease/complications , Immunoglobulin G4-Related Disease/diagnosis , Polyendocrinopathies, Autoimmune/complications , Polyendocrinopathies, Autoimmune/diagnosis , Hashimoto Disease/complications , Hashimoto Disease/diagnosis , Diabetes Mellitus, Type 1/complications , Autoimmune Diseases/complications , Autoimmune Diseases/diagnosis
2.
BMC Endocr Disord ; 22(1): 184, 2022 Jul 19.
Article in English | MEDLINE | ID: mdl-35854271

ABSTRACT

BACKGROUND: Ectopic ACTH-dependent Cushing syndrome is rarely caused by pheochromocytoma (PCC). Glucocorticoid-regulated positive feedback loops in ACTH and catecholamines were proposed in some similar cases. CASE PRESENTATION: We present here an 80-year-old man who had previously undergone surgery for a left adrenal PCC and newly developed severe hypertension, hypokalemia, and typical Cushingoid manifestations. Investigations revealed hyperglycemia, hypokalemia, and extremely high catecholamines and their metabolites, ACTH and cortisol. Imaging modalities showed a recurrent large left adrenal mass positively visualized with 123I-metaiodobenzylguanidine as well as somatostatin receptor scintigraphy. Surgical interventions were not indicated; thus, metyrapone, phentolamine, and doxazocin were initiated, which successfully controlled his symptoms and biochemical conditions. With the evidence that metyrapone administration decreased ACTH and catecholamine levels, the existence of positive feedback loops was speculated. During the terminal stages of the disease, additional metyrosine treatment successfully stabilized his physiological and biochemical conditions. Upon the patient's death, pathological autopsy was performed. Immunohistochemical analysis indicated that the tumor appeared to be co-positive with tyrosine hydroxylase (TH) as well as ACTH in most tumor cells in both PCC and liver metastasis. Most cells were clearly positive for somatostatin receptor 2 staining in the membrane compartment. The dense immunostaining of ACTH, TH, dopamine-ß-hydroxylase and the large tumor size with positive feedback loops may be correlated with high levels of ACTH and catecholamines in the circulation. CONCLUSIONS: We experienced a case of severe ectopic ACTH producing the largest reported recurrent malignant left PCC with liver metastases that presented positive feedback loops in the ACTH/cortisol and catecholamine/cortisol axes. Clinicians should be aware of the paradoxical response of ACTH on metyrapone treatment and possible steroid-induced catecholamine crisis.


Subject(s)
ACTH Syndrome, Ectopic , Adrenal Gland Neoplasms , Hypokalemia , Neuroendocrine Tumors , Pheochromocytoma , ACTH Syndrome, Ectopic/diagnosis , ACTH Syndrome, Ectopic/etiology , Adrenal Gland Neoplasms/metabolism , Adrenocorticotropic Hormone/metabolism , Aged, 80 and over , Catecholamines , Humans , Hydrocortisone , Hypokalemia/complications , Male , Metyrapone/therapeutic use , Neoplasm Recurrence, Local , Neuroendocrine Tumors/complications , Pheochromocytoma/metabolism , Pheochromocytoma/surgery
SELECTION OF CITATIONS
SEARCH DETAIL